From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum
To understand the effects of new Mpro inhibitors on SARS-CoV-2, virus was grown with gradually increasing concentrations of inhibitor, tested to check for increased resistance, and then sequenced to determine loci of resistance.